Nile Therapeutics Announces Dosing In Phase IIa Study Of CD NP In Heart Failure Patients Nile Therapeutics, Inc. (Nasdaq: NLTX), announced that it has dosed the first acute setting heart failure patient in its Phase IIa, multi-center, open-label, ascending dose clinical study of the company's lead product candidate, CD-NP, a novel chimeric natriuretic peptide, in development for the treatment of acute decompensated heart failure.
Source: www.medicalnewstoday.comOp Jaipur Nets Estimated Seizure Of 20,000 Sex Drugs In Wokingham Enforcement officers from the
Medicines and
Healthcare products Regulatory Agency (MHRA), together with assistance from Thames Valley Police, have seized approximately 20,000 unlicensed
medicines, worth an estimated £50,000. The
medicines seized consisted of Kamagra tablets and jellies, used for male impotence.
Source: www.medicalnewstoday.comUAB Joins Elite Brain Cancer Research Group Brain cancer experts at the University of Alabama at Birmingham (UAB) have been selected for membership in the Ivy Genomics-Based
Medicine Project. The project is a national consortium of cutting-edge hospitals and academic centers working to improve treatment and survival for patients with a kind of malignant brain tumor called a glioma.
Source: www.medicalnewstoday.comGlobal Warming Heats Up Need For Malaria Vaccine Says Expert August is National Immunization Awareness Month, dedicated to furthering efforts to provide what are oftentimes lifesaving vaccinations to those in need. While media coverage of the flu vaccine has become a seasonal commonplace, vaccines are currently being sought for many modern large-scale epidemics.
Source: www.medicalnewstoday.comMajor U.S. Health Groups Cite Aspirin Use Among Other Life-Saving Interventions Greater, appropriate utilization of aspirin and other preventive measures, such as quitting smoking, losing weight and lowering cholesterol, would reduce heart attacks by 36 percent over the next three decades, according to a report issued by three major U.S.
health organizations.
Source: www.medicalnewstoday.comAnti-Bacterial Personal Hygiene Products Triclosan And Triclocarban May Not Be Worth Potential Risks A new study by UC Davis researchers calls into question the widespread use of two active ingredients -- triclocarban and triclosan -- in personal hygiene products, including anti-bacterial bar and liquid soaps.
Source: www.medicalnewstoday.comNew AARP Report Finds Older Americans Have Limited Access To Home And Community-Based Services Under Medicaid A new report by AARP's Public Policy Institute finds promising signs and mixed results among state government efforts to balance long-term care (LTC) options under Medicaid. Unfortunately, according to the report, only four states spent more than 50 percent of their Medicaid LTC dollars for older people providing home and community based services (HCBS).
Source: www.medicalnewstoday.comNew Report Shows CMS Pilot Program Saving Nearly 700 Dollars Million In Improper Medicare Payments The Centers for Medicare & Medicaid Services (CMS) released a new report offering fresh evidence that the recovery audit contractors (RACs) pilot program is successfully identifying improper payments. The findings will also help the agency improve the program as it is expanded nationwide within two years, officials say. The evaluation report shows that $693.
Source: www.medicalnewstoday.comWyeth And Progenics Receive Approval From European Commission For Relistor For Opioid-Induced Constipation In Advanced Illness Patients Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX), announced that the companies have received marketing approval for RELISTOR? (methylnaltrexone bromide) subcutaneous injection from the European Commission.
Source: www.medicalnewstoday.com
# posted by Network @ 2:01 AM
